SUPER HERBS 350 mg
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
526 recalls, newest first
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.
Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Marketed Without An Approved NDA/ANDA: product marketed as a dietary supplement was found to be tainted with undeclared sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug.
Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.
Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.
Chemical Contamination: Naphthalene compound identified in the product after complaints of a petroleum odor.
Chemical contamination: Product may be contaminated with a toxic compound.
Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish